Education
About Us
Working with TipRanks
Follow Us
Spineway SA (DE:37S)
FRANKFURT:37S
37S Stock Chart & Stats
€0.19
€0.01(15.48%)
At close: 4:00 PM EST
€0.19
€0.01(15.48%)
Day’s Range― - ―
52-Week Range€0.08 - €0.26
Previous CloseN/A
Volume10.00K
Average Volume (3M)49.79K
Market Cap
€6.08M
Enterprise Value-€2.35M
Total Cash (Recent Filing)€4.03M
Total Debt (Recent Filing)€1.55M
Price to Earnings (P/E)―
Beta2.13
Next Earnings
Feb 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding35,544,390
10 Day Avg. Volume123,515
30 Day Avg. Volume49,788
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)0.94
Price to Sales (P/S)1.90
P/FCF Ratio-6.94
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
37S FAQ
What was Spineway SA’s price range in the past 12 months?
Spineway SA lowest stock price was €0.08 and its highest was €0.26 in the past 12 months.
What is Spineway SA’s market cap?
Spineway SA’s market cap is €6.08M.
When is Spineway SA’s upcoming earnings report date?
Spineway SA’s upcoming earnings report date is Feb 17, 2026 which is in 25 days.
How were Spineway SA’s earnings last quarter?
Spineway SA released its earnings results on Nov 04, 2025. The company reported -€0.042 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.042.
Is Spineway SA overvalued?
According to Wall Street analysts Spineway SA’s price is currently Overvalued.
Does Spineway SA pay dividends?
Spineway SA does not currently pay dividends.
What is Spineway SA’s EPS estimate?
Spineway SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Spineway SA have?
Spineway SA has 35,544,390 shares outstanding.
What happened to Spineway SA’s price movement after its last earnings report?
Spineway SA reported an EPS of -€0.042 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.083%.
Which hedge fund is a major shareholder of Spineway SA?
Currently, no hedge funds are holding shares in DE:37S
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Spineway SA
Spineway SA engages in the design, manufacture, and marketing of implants and surgical instruments for treating disorder of spinal column. The company offers ayers rock, an anterior cervical interbody fusion cage; blue mountain, an anterior cervical interbody fusion plate; mont blanc, a posterior thoracolumbar pedicle screws; mont blanc baby, a pediatric growing rod system; mont blanc 3d+, a coplanar alignment system; kili, an anterior lumbar interbody fusion cage; twin peaks plif bullet shaped posterior lumbar interbody fusion cages; twin peaks olif graft vascularization interbody fusion cages; twin peaks tlif transforaminal lumbar interbody fusion cages; and mont blanc mis, a mini-invasive thoracolumbar system. It also provides sonora, a biomaterial for bone regeneration. In addition, the company exports its products. Spineway SA was incorporated in 2005 and is headquartered in Ecully, France.